KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) EBIT (2016 - 2025)

Xylem has reported EBIT over the past 16 years, most recently at $353.0 million for Q4 2025.

  • Quarterly results put EBIT at $353.0 million for Q4 2025, up 32.21% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (up 21.21% YoY), and the annual figure for FY2025 was $1.2 billion, up 21.21%.
  • EBIT for Q4 2025 was $353.0 million at Xylem, up from $334.0 million in the prior quarter.
  • Over the last five years, EBIT for XYL hit a ceiling of $353.0 million in Q4 2025 and a floor of $111.0 million in Q1 2022.
  • Median EBIT over the past 5 years was $194.0 million (2022), compared with a mean of $204.5 million.
  • Peak annual rise in EBIT hit 196.3% in 2021, while the deepest fall reached 21.79% in 2021.
  • Xylem's EBIT stood at $140.0 million in 2021, then surged by 40.71% to $197.0 million in 2022, then rose by 7.11% to $211.0 million in 2023, then grew by 26.54% to $267.0 million in 2024, then skyrocketed by 32.21% to $353.0 million in 2025.
  • The last three reported values for EBIT were $353.0 million (Q4 2025), $334.0 million (Q3 2025), and $305.0 million (Q2 2025) per Business Quant data.